Posted by Michael Wonder on 13 Mar 2019
Terminal breast cancer patients push for PHARMAC inquiry and the funding of life-preserving drugs
13 March 2019 - Crowd-funding website Givealittle shouldn't be used to plug the gaps in Government drug-buying agency Pharmac's provisions for life-prolonging breast cancer treatments.
This was among the messages delivered by 10 women living with advanced breast cancer during oral submissions at the Health Select Committee hearing in Wellington on Wednesday.
The Metivivors New Zealand members were among 33,971 New Zealanders who signed online petitions calling for funding for the drugs Ibrance and Kadcyla.
